MedPath

BITOP AG

🇪🇸Spain
Ownership
-
Employees
-
Market Cap
-
Website

Application of Ectoin® Rhinitis Nasal Spray in Patients With Acute Rhinosinusitis

Completed
Conditions
Sinusitis
First Posted Date
2012-09-13
Last Posted Date
2012-09-24
Lead Sponsor
Bitop AG
Target Recruit Count
66
Registration Number
NCT01684540
Locations
🇩🇪

Dr. med. Norbert Pasch, Aachen, Germany

🇩🇪

Peter Hinterkausen, Koeln, Germany

🇩🇪

Dr. med. Wilhelm Schuetz, Juelich, Germany

and more 3 locations

Effect of Ectoin® Inhalation Solution on Subjects With Mild Bronchial Asthma

Phase 2
Completed
Conditions
Asthma
First Posted Date
2011-11-23
Last Posted Date
2011-11-23
Lead Sponsor
Bitop AG
Target Recruit Count
18
Registration Number
NCT01478152
Locations
🇩🇪

Inamed Research GmbH & Co KG, Gauting, Bavaria, Germany

The Effects of Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops Compared to Placebo

Phase 1
Completed
Conditions
Allergic Rhinitis
Allergic Conjunctivitis
Interventions
Device: Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops
Device: Placebo
First Posted Date
2011-11-15
Last Posted Date
2011-11-21
Lead Sponsor
Bitop AG
Target Recruit Count
46
Registration Number
NCT01471184
Locations
🇨🇦

Cetero Research, Mississauga, Ontario, Canada

Safety and Efficacy of Ectoin Allergy Nasal Spray and Ectoin Allergy Eye Drops in the Treatment of Seasonal Allergic Rhinitis (SAR) in Children and Adolescents

Not Applicable
Completed
Conditions
Seasonal Allergic Rhinitis
Seasonal Allergic Conjunctivitis
Interventions
Device: ect4allergy Nasal Spray (ANS01) and Eye Drops (AAT01)
Device: Placebo products
First Posted Date
2011-04-27
Last Posted Date
2011-10-13
Lead Sponsor
Bitop AG
Target Recruit Count
72
Registration Number
NCT01342601
Locations
🇩🇪

Kinderarztpraxis Bramsche, Bramsche, Germany

🇩🇪

Dr. Marlies Bölich, Jena, Germany

🇩🇪

Experimentelle Pneumologie RUB, Bochum, Germany

and more 5 locations

Efficacy and Feasibility of Ectoin® Inhalation Solution in Inflammatory Obstruction and Ageing of the Lung

Not Applicable
Completed
Conditions
COPD
Particulate Matter Induced Inflammation of the Lung
Interventions
Device: Ectoin Inhalation Solution
Device: Placebo
First Posted Date
2010-10-21
Last Posted Date
2012-08-07
Lead Sponsor
Bitop AG
Target Recruit Count
36
Registration Number
NCT01225965
Locations
🇩🇪

Institut für umweltmedizinische Forschung, Duesseldorf, Germany

Efficacy and Safety of an Ectoine-containing Cream in the Treatment of Mild to Moderate Atopic Dermatitis

Not Applicable
Completed
Conditions
Mild to Moderate Atopic Dermatitis
Interventions
Device: Atopiclair
Device: EHK02-01
First Posted Date
2010-03-03
Last Posted Date
2011-10-18
Lead Sponsor
Bitop AG
Target Recruit Count
64
Registration Number
NCT01079897
Locations
🇩🇪

Hautarztpraxis, Freiburg, Germany

🇩🇪

Hautarztzentrum Tegel, Berlin, Germany

🇩🇪

Gemeinschaftspraxis Mahlow, Mahlow, Germany

and more 1 locations
© Copyright 2025. All Rights Reserved by MedPath